0. Advocacy Graphic



The Voice of Addiction Medicine

 Leading the movement to transform America's addiction treatment infrastructure and expand access to research-validated, results-based care
ASAM_Seal_DarkBlue

ASAM's Advocacy Principles

Advocacy Webpage Graphics Teach It
TEACH addiction medicine by expanding and strengthening our workforce and dispelling stigma
Advocacy Webpage Graphics Standardize It
STANDARDIZE the delivery of addiction medicine so that more patients receive high-quality, evidence-based care
0. Advocacy Webpage Graphics Cover It
COVER addiction medicine in a way that expands patient access to coordinated, comprehensive care
 
Advocacy Homepage HR 6 Graphic
 




It's time we treat addiction like other chronic diseases 



workshop2

Advocacy Committees & Councils

ASAM's advocacy could not happen if not for the dedicated effort of our members.

0. Find a Policy Statement 1 - cropped

Public Policy Statements

Learn about ASAM's position on current policy issues.

Teamwork - smallest

Coalitions

ASAM is proud to work collaboratively with others to improve the lives of those living with addiction.
0. Advocacy Toolkits

Advocacy Toolkits

ASAM provides toolkits to help you advocate for public policies that advance addiction medicine and promote access to treatment

newspapers-3488857_1920B

ASAM commends the President’s commission for a thorough and thoughtful report that recommends an array of smart and actionable interventions

by ASAM Staff | Nov 02, 2017

Rockville, MD - Yesterday, President Trump’s Commission on Combating Drug Addiction and the Opioid Epidemic held its fifth and final meeting during which the commission approved its final report to the president. The president established the commission to review the state of drug addiction and the opioid epidemic in the United States and to make recommendations regarding how the Federal Government can best address this crisis.

ASAM commends the president’s commission for a thorough and thoughtful report that recommends an array of smart and actionable interventions that can make a meaningful difference in our nation’s current opioid epidemic. ASAM submitted comments to the commission in preparation for the report and is glad that many of those recommendations are incorporated in the final report, including:

  • The development and implementation of a national public education campaign to reduce addiction stigma;
  • Training prescribers in engagement and addiction screening strategies to identify substance use disorders and link patients to treatment;
  • Requiring that clinicians registered with the DEA to prescribe controlled substances demonstrate competency in opioid prescribing;
  • Improving the quality of treatment by, among other things, using The ASAM Criteria to help determine the appropriate level of care and services needed by patients;
  • The systematic monitoring and enforcement of the Mental Health Parity and Addiction Equity Act (MHPAEA) to ensure parity in the coverage of mental health and addiction services; and
  • Ensuring there are adequate resources for a sufficient and well-trained workforce of addiction specialist physicians and other clinicians.

Dr. Kelly Clark, MD, MBA, DFASAM, president of ASAM, had this to say about the commission’s report:

“The commission clearly considered the evidence for what works in addiction prevention, treatment, and recovery. That focus on the scientific understanding of addiction as a chronic, relapsing brain disease that can be successfully treated with evidence-based solutions should be carried through by the administration and Congress as they consider and implement the commission’s recommendations. ASAM urges our federal, state, and local elected leaders to take the commission’s report to heart and work quickly. ASAM stands ready to work with the administration and Congress to mount a united response to this public health emergency which must include sufficient funds to implement the commission’s recommendations.”

###